Skip to content
Levitate logo — Equal access to an active life. That's our moonshot

Levitate

Equal access to an active life. That's our moonshot

Founded 2020 Denmark Denmark 17 employees Seed Total: $5.50M Medical Devices, Pharmaceutical

General Information

Company Name Levitate
Founded Year 2020
Location Denmark Denmark
Founders / Decision Makers
Team member
Employees 17
Industries Medical Devices, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Levitate. To contact Levitate, visit letslevitate.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Levitate compare?

A PDF of Levitate and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Levitate soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Levitate

Levitate is a Denmark-based startup with a mission to provide equal access to an active life through the production of high-quality sports prosthetics for amputees at an affordable cost. Founded in 2020, the company operates in the pharmaceutical industry. In its latest funding round on 23 February 2021, Levitate secured a kr5.50M Seed Round investment from PreSeed Ventures and Vaekstfonden. Levitate's vision and innovative approach to addressing the needs of amputees position it as a promising investment opportunity, catering to both social impact and financial return objectives. With its commitment to enhancing accessibility and affordability in the prosthetics market, Levitate stands as a compelling player in the healthcare and assistive technology sectors, attracting the interest of venture capital firms seeking impactful and profitable investment prospects.

Business keywords: Prosthetics, Running blades, Sports, Technology, Athletic equipment, Amputees, Reconstructive surgery

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round kr5.50M 2
PreSeed Ventures, Vaekstfonden
23 Feb 2021

Levitate Alternatives & Competitors

View All Alternatives
Levitate vs
AMW GmbH
AMW GmbH Germany

Controlled drug delivery for superior treatment. For patients, worldwide.

97 employees
Health Care, Medical Devices
Levitate vs
NewBridge Pharmaceuticals
NewBridge Pharmaceuticals United Arab Emirates

A regional specialty company providing a one-stop-solution to the MENA region for USFDA/EMA approved...

Series C
252 employees
Biotechnology, Medical Devices
Levitate vs

To be the leader in advancing patient care and digestive health by promoting excellence and innovati...

126 employees
Health Care, Medical Devices

FAQ About Levitate

Equal access to an active life. That's our moonshot
Levitate was founded in 2020.
Levitate is headquartered in Denmark.
Levitate operates in Medical Devices and Pharmaceutical. Its work centres on Prosthetics, Running blades, Sports and Technology.
Levitate has approximately 17 employees.
Levitate has completed 1 funding round, raising a total of $5.50M. The latest funding stage is Seed.
Top alternatives and competitors to Levitate include AMW GmbH, NewBridge Pharmaceuticals, American Society for Gastrointestinal Endoscopy (ASGE), RxPack. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Levitate and AMW GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Levitate, https://bouncewatch.com/company/levitate, updated 14 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout